The Latest Breaking News from Novo Nordisk

The stock market surged to highs on Donald Trump's election win. A Fed rate cut and a slew of big earnings reports filled out a busy week.

The weight-loss industry may become more accessible to the average American.

Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a…

Madrigal stock catapulted again Friday after Novo Nordisk published not "game-changing" results for its MASH treatment.

Labour’s plans to give weight loss drugs to the unemployed may not just fail: it could backfire, therapist Sally Baker explains

Demand for the popular weight loss and diabetes drugs has spiked dramatically in recent years

As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the battle between the pharmaceutical giants providing them — and delves into what exactly sets their products apart

Shifting blame to the victims of economic policy is an old trick by politicians. Now they’re using obesity to tackle joblessness

Team Novo Nordisk rider among a trio of top Australians in elite men's field